Holen Sie sich die Stockscreener-App
1.55
0.00%
0.00
Schlusskurs vom Vortag:
$1.55
Offen:
$1.55
24-Stunden-Volumen:
130.67K
Relative Volume:
2.11
Marktkapitalisierung:
$869.18M
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
+1.97%
1M Leistung:
-18.85%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.53
$1.75
1-Wochen-Bereich:
$1.47
$1.75
52-Wochen-Spanne:
$1.42
$14.50
Sl Science Holding Ltd Stock (SLBT) Company Profile
Firmenname
Sl Science Holding Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare SLBT vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLBT
Sl Science Holding Ltd
|
1.55 | 869.18M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Sl Science Holding Ltd Aktie (SLBT) Neueste Nachrichten
The CEO buys 4.55M ordinary shares in SL Science Holding (SLBT). - Stock Titan
A CEO buys shares without changing his total ownership in SL Science Holding (SLBT). - Stock Titan
SLBT Price Today: SL Science Holding Limited Stock Price, Quote & Chart | MEXC - MEXC
Business council charts new SL–Canada trade drive - Island.lk
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Sl Science Holding Ltd stock hits 52-week low at 2.45 USD - Investing.com Canada
Sl Science Holding Ltd stock hits 52-week low at 2.45 USD By Investing.com - Investing.com South Africa
Sl Science Holding Ltd stock hits 52-week low at 2.45 USD - investing.com
September 2026 Nasdaq Stock Market Bell Ceremonies - Nasdaq
Morning Market Movers: RARE, BIAF, TLYS, SNOW See Big Swings - RTTNews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
NetApp, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session - Benzinga
Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket - Benzinga
SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company - The Manila Times
SL Science Rings Nasdaq Bell, Marks First Quarter as Public Company and Advances γδ T Cell Therapy Platform - Quiver Quantitative
SL Science Rings Nasdaq Bell, Marks First Quarter as Public Company and Advances γδ T Cell Therapy Platform - Quiver Quantitative
SL Science Holding Discloses Resignation of Vice President of Finance - theglobeandmail.com
Johnson Lau Steps Down as VP of Finance at SL Science Holding Ltd - Kalkine Media
SL Science Holding Discloses Resignation of Vice President of Finance - TipRanks
SL Science (SLBT) finance VP steps down with no insider trades - Stock Titan
SL Science (SLBT) finance VP to step down Aug. 31 - Stock Titan
SL Science licensor files exosome drug master file with FDA - Investing.com India
SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform - manilatimes.net
A new FDA filing covers exosomes; studies indicate they can cross the blood-brain barrier - Stock Titan
SL Science licensor files exosome drug master file with FDA - investing.com
SL Science Holding Ltd Switches Audit Firm to TAAD LLP in Late August 2026 - TipRanks
SL Science Holding (SLBT) Stock May Be Fully Priced Even After A 74% Fall - Yahoo Finance
SL Science Holding Limited Ordinary Shares (NASDAQ: SLBT) Stock Price, News & Analysis - kalkine.com.au
SL Science Holding Limited Ordinary Shares (NASDAQ: SLBT) Stock Price, News & Analysis - kalkine.ca
SL Science Holding Ltd SEC Filing (Aug 13, 2026) - Stock Titan
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
RBGLY Stock Price and Chart — OTC:RBGLY - TradingView
SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma - The Manila Times
SL Science Holding Limited Announces Publication of Peer-Reviewed Framework for γδ T Cell Therapy in Glioblastoma - Quiver Quantitative
Brain Cancer Cell Therapy Trials Must Track Cells, Review Says - Stock Titan
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
AbCellera Stock Soars 30% After Menopause Drug ABCL635 Hits Phase 2 Success In Hot Flash Trial Results - International Business Times Australia
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
Upcoming and recent IPOs – IPOs calendar - Yahoo Finance UK
Operating expenses (excl. COGS) of SL Science Holding Limited – NASDAQ:SLBT - TradingView
SL Science Holding Ord Shs (SLBT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
SL Science Holding (NASDAQ: SLBT) files to register resale of 1.04M shares - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Saol Therapeutics Announces the Acceptance of Resubmission of SL1009 (DCA) by the FDA with PDUFA Date of Dec. 30, 2026 - Yahoo Finance
SL Science Holding Ord Shs (SLBT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SLBT|SL Science Holding Ord Shs|Price:3.200|Chg%:+0.555 - TradingKey
SL Science Holding Ord Shs (SLBT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SL Science Holding Ord Shs (SLBT) Cash Flow - TradingKey
SL Science Holding Ord Shs (SLBT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Finanzdaten der Sl Science Holding Ltd-Aktie (SLBT)
Es liegen keine Finanzdaten für Sl Science Holding Ltd (SLBT) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):